Preliminary safety and efficacy of givastomig, a novel claudin 18.2/4-1BB bispecific antibody, in combination with nivolumab and mFOLFOX in metastatic gastroesophageal carcinoma (mGEC) Meeting Abstract
| Authors: | Klempner, S. J.; Dayyani, F.; Kratz, J.; Kim, S.; Xu, C.; Ahlers, C. M.; Liu, X.; Chung, J. K.; Sabbatini, P.; Dennis, P. A.; Lee, S.; Jeon, J.; Ku, G. |
| Abstract Title: | Preliminary safety and efficacy of givastomig, a novel claudin 18.2/4-1BB bispecific antibody, in combination with nivolumab and mFOLFOX in metastatic gastroesophageal carcinoma (mGEC) |
| Meeting Title: | ESMO Gastrointestinal Cancers Congress Congress 2025 |
| Journal Title: | Annals of Oncology |
| Volume: | 36 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2025 Jul 2-5 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2025-07-01 |
| Start Page: | S151 |
| End Page: | S152 |
| Language: | English |
| ACCESSION: | WOS:001545624000059 |
| DOI: | 10.1016/j.annonc.2025.05.404 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 388MO -- Source: Wos |
